Skip to main content
. 2020 Dec 28;48(6):2031–2037. doi: 10.1007/s00259-020-05165-3

Fig. 2.

Fig. 2

A 53-year-old female patient showed a slightly decreasing pulmonary metastasis, which, however, completely lost PSMA expression during therapy with cabozantinib